Barbara Spellerberg
Albert Einstein Allee 11
Ulm, BW 89081, Germany
Ulm, BW 89081, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Human histone fragments display antibacterial properties against Pseudomonas aeruginosa.
Journal: Frontiers in immunology
Published: May 12, 2026
Broad-Spectrum Antiviral and Antibacterial Activity of the Scorpion Venom Peptide HP1090.
Journal: Toxins
Published: April 30, 2026
The OEGMA-based hydrogel is active against all species of the ESKAPE pathogens, Streptococcus mutans and the pathogenic yeast Candida albicans.
Journal: Scientific reports
Published: February 13, 2026
Lineage-encoded genomic determinants of neonatal invasive Group B Streptococcal disease.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 13, 2026
The Antimicrobial Peptide C14R Is Active Against All Pathogenic Species of the ESKAPE Group.
Journal: Antibiotics (Basel, Switzerland)
Published: January 07, 2026
Phage Display-Derived Peptides Have Neutralizing Activities Against Biofilm Formation by Candida albicans, Candidozyma auris and Candida parapsilosis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 17, 2025
Amyloid fibrils of the Als5p-derived peptide NH2-SNGIVIVATTRTV-COOH influence the biofilm formation of Candida albicans by shape-edging microcolony morphology.
Journal: Virulence
Published: December 10, 2025
CRISPR typing and phage content of colonizing Group B Streptococci from healthy Egyptian women.
Journal: Frontiers in cellular and infection microbiology
Published: May 27, 2025
The antimicrobial peptide Angie 5 inhibits TcdA and TcdB from Clostridioides difficile.
Journal: Cellular and molecular life sciences : CMLS
Published: November 14, 2024
Robust Fluorometric Aptamer Assay for Direct and Rapid Detection of Clinical Isolates of Candida spec.
Journal: International journal of molecular sciences
Published: February 16, 2024
The Designed Pore-Forming Antimicrobial Peptide C14R Combines Excellent Activity against the Major Opportunistic Human Pathogen Pseudomonas aeruginosa with Low Cytotoxicity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 08, 2023
Last Updated: 09/26/2026